Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 2/20 | 0.54 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.54 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
| ▸ | LTA4H | P09960 | 1/20 | 0.40 |
| ▸ | ABAT | P80404 | 1/20 | 0.39 |
| ▸ | THRA | P10827 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | BCL2 | P10415 | 1/20 | 0.39 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.39 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19038964 | 0.88 | ESR1 (0.50) | ESR1ESR2KEAP1MEN1MAPT | |
| SCHEMBL13609112 | 0.86 | ESR1 (0.59) | ESR1ESR2KEAP1MEN1MAPT | |
| SCHEMBL14998893 | 0.86 | CALM1 (0.53) | ESR1ESR2LTA4H | |
| SCHEMBL14864969 | 0.86 | ESR1 (0.48) | ESR1ESR2KEAP1MEN1MAPT | |
| SCHEMBL30375403 | 0.84 | ESR1 (0.56) | ESR1ESR2KEAP1MEN1MAPT | |
| SCHEMBL1456505 | 0.84 | ESR1 (0.56) | ESR1ESR2KEAP1MEN1MAPT | |
| SCHEMBL19039010 | 0.84 | ESR1 (0.46) | ESR1ESR2KEAP1MEN1MAPT | |
| SCHEMBL19039023 | 0.84 | ESR1 (0.42) | ESR1ESR2KEAP1MEN1MAPT | |
| SCHEMBL19039043 | 0.84 | ESR1 (0.42) | ESR1ESR2KEAP1MEN1MAPT | |
| SCHEMBL19038989 | 0.84 | ESR1 (0.42) | ESR1ESR2KEAP1MEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 190 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1623274-A2 | PHOTORESIST COMPOSITIONS | AZ Electronic Materials USA Corp. (US) | 2006-02-08 | — | — | EP | claimed |
| WO-2004088423-A2 | PHOTORESIST COMPOSITIONS | AZ ELECTRONIC MATERIALS USA CORP. (US) | 2004-10-14 | — | — | WO | claimed |
| US-20040197704-A1 | Photoresist compositions | AZ ELECTRONIC MATERIALS USA CORP. | 2004-10-07 | — | — | US | claimed |
| US-6790582-B1 | NOVOLAK RESIN PARTIALLY ESTERIFIED WITH NAPHTHOQUINONEDIAZIDOSULFONYL GROUP; DILUTION RESIN(S), AND SOLVENT | CLARIANT FINANCE BVI LIMITED (VG) | 2004-09-14 | — | — | US | claimed |
| US-12497558-B2 | Colour change composition and compounds | THERMOGRAPHIC MEASUREMENTS LTD (GB) | 2025-12-16 | — | — | US | disclosed |
| US-12297357-B2 | Temperature-sensitive indicator | THERMOGRAPHIC MEASUREMENTS LTD (GB) | 2025-05-13 | — | — | US | disclosed |
| EP-3344468-B1 | COMPOUND FOR USE IN COLOUR CHANGE COMPOSITIONS | THERMOGRAPHIC MEASUREMENTS LTD (GB) | 2025-03-05 | — | — | EP | disclosed |
| US-12202981-B2 | Compound for use in colour change compositions | SOCIETE BIC (FR) | 2025-01-21 | — | — | US | disclosed |
| US-20240384116-A1 | MODIFIED EPOXY RESIN AND ELECTRODEPOSITION COATING MATERIAL | KANSAI PAINT CO., LTD. (JP) | 2024-11-21 | — | — | US | disclosed |
| CN-115362193-B | Epoxy resin and electrodeposition paint | 关西涂料株式会社 | 2024-11-08 | — | — | CN | disclosed |
| EP-3349990-B1 | COMPOUND FOR USE IN COLOUR CHANGE COMPOSITIONS | SOCIéTé BIC (FR) | 2024-10-30 | — | — | EP | disclosed |
| CN-118715262-A | Curable resin composition | 太阳控股株式会社 | 2024-09-27 | — | — | CN | disclosed |
| US-6790582-B1 | NOVOLAK RESIN PARTIALLY ESTERIFIED WITH NAPHTHOQUINONEDIAZIDOSULFONYL GROUP; DILUTION RESIN(S), AND SOLVENT | CLARIANT FINANCE BVI LIMITED (VG) | 2004-09-14 | — | — | US | disclosed |
| US-6750313-B2 | HIGH REFRACTIVE INDEX AND LOW DISPERSION CHARACTERISTICS; OPTICAL LENSES, FILMS, DISCS; POLYCARBONATE RESIN CONTAINING A PHOSPHONIC ACID GROUP | TORAY INDUSTRIES, INC. (JP) | 2004-06-15 | — | — | US | disclosed |
| US-6558867-B2 | Blend of novolak resin, quinonediazidosulfonate compound andphenolic compound | SHIN ETSU CHEMICAL CO., LTD. (JP) | 2003-05-06 | — | — | US | disclosed |
| US-20030013836-A1 | Resin composition and articles molded therefrom | TORAY INDUSTRIES, INC., A CORPORATION OF JAPAN (JP) | 2003-01-16 | — | — | US | disclosed |
| EP-1270646-A1 | RESIN COMPOSITION AND ARTICLES MOLDED THEREFROM | TORAY INDUSTRIES, INC. (JP) | 2003-01-02 | — | — | EP | disclosed |
| EP-1146394-A1 | PHOTOSENSITIVE RESIN COMPOSITION AND METHOD FOR IMPROVING DRY ETCHING RESISTANCE OF PHOTOSENSITIVE RESIN COMPOSITION | CLARIANT INTERNATIONAL LTD. (CH) | 2001-10-17 | — | — | EP | disclosed |
| US-20010019808-A1 | Lift-off resist compositions | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2001-09-06 | — | — | US | disclosed |
| EP-0943640-A1 | HIGHLY HEAT-RESISTANT, HIGH-PURITY POLYARYLATE AND FILM PRODUCED FROM THE SAME | UNITIKA LTD. (JP) | 1999-09-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12297357-B2 | Temperature-sensitive indicator | NCS1, TREH, NEFM | ESR1 236/4885ESR2 1581/4885KEAP1 2900/4885 |
| US-12202981-B2 | Compound for use in colour change compositions | TYR, C1R, CBR3 | ESR1 413/4885ESR2 837/4885KEAP1 1965/4885 |
| US-12497558-B2 | Colour change composition and compounds | C5, C9, C3AR1 | ESR1 20/4885ESR2 77/4885KEAP1 923/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.